164 related articles for article (PubMed ID: 33036678)
21. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y
Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490
[TBL] [Abstract][Full Text] [Related]
22. Positive predictive value of fecal immunochemical test for high-risk colonic adenomas and carcinoma: A health maintenance organization cohort screening study in Lebanon.
Chehab H; BouDaher H; Mokahal AE; ElHaddad A; Rimmani H; Hamadeh G; Tawil A; Sharara AI
Arab J Gastroenterol; 2021 Jun; 22(2):174-176. PubMed ID: 33965367
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection.
Xu H; Chen H; Hu J; Xiong Z; Li D; Wang S; Yu J
BMC Gastroenterol; 2022 Aug; 22(1):384. PubMed ID: 35963995
[TBL] [Abstract][Full Text] [Related]
24. Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer.
Zorzi M; Hassan C; Capodaglio G; Baracco M; Antonelli G; Bovo E; Rugge M
Endoscopy; 2020 Oct; 52(10):871-876. PubMed ID: 32356282
[TBL] [Abstract][Full Text] [Related]
25. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
26. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
Chen H; Werner S; Brenner H
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
[TBL] [Abstract][Full Text] [Related]
27. Short Term Outcomes of Using Fecal Immunochemical Test for a Pilot Colorectal Cancer Screening Program. A Single Center Study on 3024 Consecutive Patients.
Constantin A; Cazacu I; Ciocârlan M; Constantinescu C; Baltog G; Balahura C; Doraş I; Filip S; Filip G; Panazan I; Piţigoi D; Pirvu V; Turcu F; Copăescu C; Săftoiu A
Chirurgia (Bucur); 2020; 115(4):448-457. PubMed ID: 32876018
[No Abstract] [Full Text] [Related]
28. Fecal microbial DNA markers serve for screening colorectal neoplasm in asymptomatic subjects.
Liang JQ; Wong SH; Szeto CH; Chu ES; Lau HC; Chen Y; Fang J; Yu J; Sung JJ
J Gastroenterol Hepatol; 2021 Apr; 36(4):1035-1043. PubMed ID: 32633422
[TBL] [Abstract][Full Text] [Related]
29. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
30. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
31. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.
Alsayid M; Singh MH; Issaka R; Laleau V; Day L; Lee J; Allison J; Somsouk M
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1593-1597.e1. PubMed ID: 29660528
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
Caviglia GP; Cabianca L; Fagoonee S; Gili FM
Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
[TBL] [Abstract][Full Text] [Related]
33. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
34. Screening for colon cancer: A test for occult blood.
Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
[TBL] [Abstract][Full Text] [Related]
35. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Jun; 32(6):481-493. PubMed ID: 28667446
[TBL] [Abstract][Full Text] [Related]
37. Detection Rate of Colorectal Cancer or Precancer Adenoma by Colonoscopy After 1, 2, or 3 Positive Results via Fecal Immunochemical Testing.
Hancock JA; Palmer GA
Lab Med; 2019 Jul; 50(3):263-267. PubMed ID: 30657950
[TBL] [Abstract][Full Text] [Related]
38. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
[TBL] [Abstract][Full Text] [Related]
40. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]